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DTI values for different WHO ATC drug classes
Single parameter one-way ANOVA test was run on the data for 13 WHO ATC drug categories to understand the variations in the physicochemical, PD, PK parameters, their contributions to DTI or DTI between different drug groups. As seen in Table S1 , except the OBA, IC50 at the target, and contributions of log D and IC50 at CYP450 to DTI, all the parameters considered were significantly (P = 0.05) different among these groups. These results thus can be used to identify properties which differentiate withdrawn drugs from other drug categories. and physicochemical contributions to DTI, it appears that toxicity is a combination of all these factors.
Acalabrutinib (DTI = 1.10), a newly introduced kinase inhibitor, has FDA-label warning for haemorrhage and secondary infections. DTI prediction suggests a chance for toxicity and drug interactions. Topotecan with lowest DTI value has been associated with mild serum enzyme elevations, but rarely to liver injury. Its use may have bone marrow toxicity at recommended doses which can be controlled with dosage adjustments. (22) Horizontal view of DTI applications in drug discovery process. 
Methods

Data collection
Names of the small molecule approved drugs were identified from the Drug Bank (version 5.0.11). (23) The 
Data analysis
The PK, PD and physicochemical data collected was used to estimate "Drug Toxicity Index" (DTI) Dabigatran, a prodrug, was not considered for estimation of DTI. These results are suggestive only since one set of data points was for placebo and another ignored the contribution of the prodrug aspirin (ASA) to the DTI values of the ASA and Clopidogrel combinations Following average DTI values for the respective therapeutic areas were used as cut off; a 1.12, b 1.4, c 1.72, d 1.09. e For withdrawn category criteria of LEI < 0.3, LLE < 5, DTI > 0.67 (avg for withdrawn), ACD log D >3 and log P > 3 was used. For exposure based TI the criteria was IC50/Cmax value between 0.5-2. For classical TI (CYP450, hERG, BSEP) the criteria was ≥ 30. None of the antibiotic class of drugs considered here had a dose < 100 mg. Average values used as cut off for PD on/off target, PK and physicochemical parameters are given in Table 3 . 
